# GLP-1 Effects on Insulin and Glucagon in PTDM

> **NCT02591849** · NA · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 24 (actual)

## Conditions studied

- Post-transplant Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** Glucagon-like peptide-1 (GLP-1)
- **OTHER:** Isotonic saline
- **OTHER:** Hyperglycemic clamp

## Key facts

- **NCT ID:** NCT02591849
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02591849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02591849, "GLP-1 Effects on Insulin and Glucagon in PTDM". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02591849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*